Relapsing-remitting multiple sclerosis patients exhibit differential natural killer functional subpopulations.

These results suggest that remission RRMS patients, although in an inactive stage of MS, present circulating NK cells with an activation phenotype, supporting the idea that NK cells may be relevant mediators in the MS pathophysiology.